Black Friday Sale - Ends Soon!
-35% Off Everything
BioNTech SE (BNTX)
Last Price$117.8(2.4%)
Market Cap$20.7B
BNTX overview
Crunching data... Almost there!
1W 4.6%
1M 3.8%
6M 27.0%
YTD 5.4%
1Y 19.3%
3Y (66.9%)
5Y 445.8%
10Y 742.4%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
BNTX key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
BNTX Intrinsic value
BNTX Intrinsic value overview
BNTX Historical intrinsic value
BNTX Financials
BNTX Income statement
Crunching data... Almost there!
BNTX Balance sheet
Crunching data... Almost there!
BNTX Cash flow statement
Crunching data... Almost there!
BNTX Financial ratios
BNTX Growth
Crunching data... Almost there!
BNTX Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more BNTX fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of BioNTech SE (BNTX) stock?
As of today, intrinsic value of BioNTech SE is $162.3.
Is BioNTech SE (BNTX) stock undervalued or overvalued?
As of today, BioNTech SE is undervalued by 37.1%, compared to the current market share price of $117.8.
What is BioNTech SE (BNTX) stock rating?
As of today, BioNTech SE has a stock rating of 7 (out of 10), which is considered Great.
is BioNTech SE (BNTX) a good stock to buy?
As of today, BioNTech SE has a Great stock rating, which is 37.1% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.